Botulinum toxin in motor disorders

被引：9
|
作者：
Bentivoglio, AR
Albanese, A
机构：
[1] Univ Lausanne, Dept Neurol, CH-1011 Lausanne, Switzerland
[2] Univ Cattolica Sacro Cuore, Dept Neurol, Rome, Italy
来源：
CURRENT OPINION IN NEUROLOGY | 1999年 / 12卷 / 04期
关键词：
D O I：
10.1097/00019052-199908000-00012
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Advances in the clinical use of botulinum neurotoxins continue. Of interest to the neurologist is the advanced practice in the treatment of focal dystonia and the new developments on other dyskinesias and on autonomic control of smooth muscle motility. New toxin serotypes are now being tested; their availability will improve clinical practice and will possibly lead to combined treatments, Indications in spasticity and in juvenile cerebral palsy are now under scrutiny. The combination of focal chemodenervation with specific rehabilitation procedures enables new development in this field. Curr Opin Neurol 12:447-456. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码：447 / 456
页数：10
相关论文
共 50 条
12345